Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

3148

LikeLikedUnlike

676-690 of 921

MinuteCE®
Optimizing Care for Patients with CKM Syndrome: A Multidisciplinary Approach
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
  Peer
- Jürgen Floege, MD
  Peer
- Muthiah Vaduganathan, MD, MPH
  Peer
1.00 credits 4 episodes
Definition and Staging of CKM Syndrome
MinuteCE®
Definition and Staging of CKM Syndrome
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
  Peer
1.00 program credits
Screening for CKM Syndrome
MinuteCE®
Screening for CKM Syndrome
- Jürgen Floege, MD
  Peer
1.00 program credits
Comprehensive Management of Individuals with CKM Syndrome
MinuteCE®
Comprehensive Management of Individuals with CKM Syndrome
- Muthiah Vaduganathan, MD
  Peer
1.00 program credits
Case-Based Learning and Future Directions
MinuteCE®
Case-Based Learning and Future Directions
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
  Peer
- Muthiah Vaduganathan, MD, MPH
  Peer
- Jurgen Floege MD
  Peer
1.00 program credits
Bringing Treatment Into Focus: Biomarker-Driven First-Line Therapy for Metastatic Gastric/GEJ Cancers
CME/CE
Bringing Treatment Into Focus: Biomarker-Driven First-Line Therapy for Metastatic Gastric/GEJ Cancers
- David H. Ilson, MD, PhD
  Peer
- Sunnie Kim, MD
  Peer
1.00 credits
advertisement
MinuteCE®
Bridging the Gap: ns-MRAs in Cardiovascular-Kidney-Metabolic Syndrome Care
- Pardeep Jhund, MD, PhD
  Peer
- Hiddo L. Heerspink, PhD
  Peer
- John McMurray, MD
  Peer
- Akshay S. Desai, MD
  Peer
- Csaba P. Kovesdy, MD
  Peer
- Finnian R. McCausland, MD
  Peer
- Orly Vardeny, MD
  Peer
- Muthiah Vaduganathan, MD, MPH
  Peer
1.25 credits 10 episodes
MOA Deep Dive: The MRA Spectrum
MinuteCE®
MOA Deep Dive: The MRA Spectrum
- John McMurray, MD
  Peer
- Hiddo L. Heerspink, PhD
  Peer
1.25 program credits
Nonsteroidal MRAs: The CKD/T2D Advantage
MinuteCE®
Nonsteroidal MRAs: The CKD/T2D Advantage
- John McMurray, MD
  Peer
- Pardeep Jhund, MD, PhD
  Peer
1.25 program credits
Nonsteroidal MRAs: The CKD/T1D Potential
MinuteCE®
Nonsteroidal MRAs: The CKD/T1D Potential
- John McMurray, MD
  Peer
- Hiddo L. Heerspink, PhD
  Peer
1.25 program credits
Emerging Evidence in HF Care
MinuteCE®
Emerging Evidence in HF Care
- Pardeep Jhund, MD, PhD
  Peer
- John McMurray, MD
  Peer
1.25 program credits
The Evolving Role of MET TKIs in NSCLC
CME/CE
The Evolving Role of MET TKIs in NSCLC
- Gilberto de Lima Lopes, Jr, MD, MBA, FASCO
  Peer
- Jyoti Patel, MD
  Peer
0.75 credits
advertisement
MinuteCE®
Precision Timing: Unveiling the Impact of CDK4/6 Inhibition in Early HR+/HER2- Breast Cancer
- Hope S. Rugo, MD, FASCO
  Peer
- Nadia Harbeck, MD, PhD
  Peer
1.25 credits 10 episodes
Treatment Intensification in HR+/HER2- EBC: Who and When?
MinuteCE®
Treatment Intensification in HR+/HER2- EBC: Who and When?
- Hope S. Rugo, MD, FASCO
  Peer
- Nadia Harbeck, MD, PhD
  Peer
1.25 program credits
Endpoints in Adjuvant Breast Cancer Trials: Implications for Clinical Practice
MinuteCE®
Endpoints in Adjuvant Breast Cancer Trials: Implications for Clinical Practice
- Hope S. Rugo, MD, FASCO
  Peer
- Nadia Harbeck, MD, PhD
  Peer
1.25 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended